HOME >> MEDICINE >> NEWS
Landmark dialysis study findings could greatly simplify treatment of kidney disease with peritoneal dialysis

Montreal, Canada, June 28, 2001 - Data presented from the largest randomized controlled clinical trial ever completed in dialysis patients suggest that peritoneal dialysis (PD), a flexible home-based dialysis treatment for people with chronic kidney failure, might have far broader applicability than current practice patterns suggest. This study, led by researchers in Mexico and conducted under the auspices of the Mexican healthcare authorities , and supported by Baxter Healthcare Corporation and its Mexico affiliate, was presented this week at an invited scientific session at the IX Congress of the International Society for Peritoneal Dialysis (ISPD) in Montreal.

According to Peter G. Blake, M.D., associate professor of medicine at the University of Western Ontario, Canada, and member of the National Kidney Foundation Dialysis Outcomes Quality Initiative (DOQI) Peritoneal Dialysis Adequacy Workgroup, "This is a pivotal study for the nephrology community worldwide because it is a high quality, multi-center, prospective, randomized, controlled trial with a large number of patients, which gives us highly credible results. The study provides us with statistically sound evidence for simplifying our PD treatment practices-without sacrificing patient outcomes. The findings, which challenge existing treatment recommendations for peritoneal dialysis, should make it significantly easier for physicians to prescribe peritoneal dialysis and may also make it possible for many more patients to benefit from the therapy."

Declining kidney function results in higher levels of toxins and waste products in the blood. When the kidneys no longer adequately eliminate toxins from the bloodstream, peritoneal dialysis helps to clear these unwanted substances through the peritoneal membrane, commonly measured in terms of small solute clearances like urea and creatinine. This membrane, located in the abdominal region, serves as the therapy's natural waste filter and
'"/>

Contact: Stephanie Lazor
stephanie.lazor@mslpr.com
212-213-7265
Manning Selvage & Lee
28-Jun-2001


Page: 1 2 3 4 5

Related medicine news :

1. Landmark survey reveals asthma in children remains significantly out of control in the United States
2. Landmark antidepressant analysis demonstrated significant efficacy of Effexor®/Effexor XR
3. Landmark study shows coenzyme Q10 slows progressive decline in Parkinsons disease
4. Landmark XENDOS study shows Xenical prevents or delays the development of type 2 diabetes
5. Landmark study demonstrates potential for nerve regeneration treatment of stroke
6. Landmark study results published in NEJM highlight breakthrough treatment for heart failure
7. Landmark study uncovers reasons behind recurring back injury
8. Landmark clinical trial at 22 medical centers finds implanted heart pumps lengthen and improve lives of terminally ill heart failure patients
9. Landmark school-based social influences smoking-prevention program found not to work
10. U.S., British scientific societies honor penicillin as International Chemical Landmark
11. CODE-2*: Landmark study on the costs of type 2 diabetes in Europe

Post Your Comments:
(Date:5/21/2013)... Minn. Positively charged gold nanoparticles are usually ... to avoid nanoparticle toxicity. Mayo Clinic researchers found ... nanoparticles effective against ovarian cancer cells. The discovery ... the Journal of Biological Chemistry ., "This ... cancer cells by preventing the cell death or ...
(Date:5/21/2013)... May 21, 2013 Residents in St. ... dental care now that Dr. David Sherberg, DMD, has ... South. , Dr. Sherberg provides preventive, restorative and cosmetic ... and his friendly team provide a wide variety ... grafting, root canal therapy, crowns, bridges, dentures, dental implant ...
(Date:5/21/2013)... TheBeautyPlace.com helps brides to breathe a little easier on ... including all the essentials a glowing bride or bridal ... Day. , TheBeautyPlace.com features Wedding Day essentials to give ... Flowers blooming and warmer weather indicates the springtime, which ... Day to October, brides to be can finally celebrate ...
(Date:5/21/2013)... Dr. Francine Kaufman , inventor of Extend ... patients in the 1980s: It weighed several pounds and was jokingly ... it could only be used in the hospital setting. , The ... the advantages are greater as well. The insulin pump is now ... often on a belt or a pocket. It delivers fast-acting insulin ...
(Date:5/21/2013)... 21, 2013 The producers of Net ... dates for Peterborough, Ontario, Canada. The area is famous for ... Canadians and Americans. It is located an hour from Toronto ... is located in the Kawartha Hills, home to several towns, ... stability to the area. Residents and visitors to this region ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 3Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 2Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4Health News:Net Worth Business TV Announces May Air Dates for Peterborough, Ontario 2
(Date:5/21/2013)... 2013  Zacks.com announces the list of stocks featured ... Research analysts discuss the latest news and events impacting ... the blog include Actavis, Inc.,s (NYSE: ACT ), ... TOT ), Petrobras (NYSE: PBR ) and ... (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO ) Get the ...
(Date:5/21/2013)... 2013  IsoRay, Inc. (AMEX: ISR ), ... into an exclusive international distribution agreement with IASIS Medical ... Greece . IsoRay is a medical ... radioisotope applications for brain cancer, lung cancer, head and ... IASIS Medical is ideally suited to support ...
(Date:5/21/2013)... Hurel Corporation ("Hurel"), a world-leading provider of ... today announced the appointment of James S. ... of Directors. Dr. MacDonald is the former Executive Vice ... ("SPRI"), which was the pharmaceutical development arm of Schering ... in 2009. Over a career that has ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 4The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 5IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
Cached News: